AMRX
Amneal Pharmaceuticals, Inc.
18.30$
+1.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Amneal Pharmaceuticals, Inc. (AMRX) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/13/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/12/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/12/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/11/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/10/2026 | Current report (8-K) | Amneal Pharmaceuticals, Inc. (AMRX): Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/03/2026 | Current report (8-K) | Amneal Pharmaceuticals, Inc. (AMRX): Entry into a Material Definitive Agreement | View report ↗ |
| 07/31/2026 | Current report (8-K) | Amneal Pharmaceuticals, Inc. (AMRX): Submission of Matters to a Vote of Security Holders | View report ↗ |
| 07/30/2026 | Current report (8-K) | Amneal Pharmaceuticals, Inc. (AMRX): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.